Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Bucher

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Epidemiology and Infection|February 28, 2008
Predicting mortality with pneumonia severity scores: importance of model recalibration to local settingsP Schuetz, M Koller, M Christ-Crain, et al.
HIV Medicine|November 26, 2002
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort StudyH C Bucher, M Bichsel, P Taffé, et al.
HIV Medicine|March 20, 2014
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovirJ Young, Q Wang, C A Fux, et al.
The European Respiratory Journal|June 1, 2007
Respiratory symptoms, atopy and bronchial hyperreactivity in professional firefightersD Miedinger, P N Chhajed, D Stolz, et al.
HIV Medicine|September 8, 2009
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS)A U Scherrer, B Hasse, V von Wyl, et al.
The British Journal of Surgery|February 7, 2018
Systematic review and simulation study of ignoring clustered data in surgical trialsS Dell-Kuster, R A Droeser, J Schäfer, et al.
HIV Medicine|December 13, 2017
Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversionO T Stirrup, A J Copas, A N Phillips, et al.
HIV Medicine|November 8, 2017
Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infectionJ Young, C Smith, R Teira, et al.
HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.
AIDS (London, England)|November 4, 2000
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort StudyO T Rutschmann, P L Vernazza, H C Bucher, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Epidemiology and Infection|February 28, 2008
Predicting mortality with pneumonia severity scores: importance of model recalibration to local settingsP Schuetz, M Koller, M Christ-Crain, et al.
HIV Medicine|November 26, 2002
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort StudyH C Bucher, M Bichsel, P Taffé, et al.
HIV Medicine|March 20, 2014
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovirJ Young, Q Wang, C A Fux, et al.
The European Respiratory Journal|June 1, 2007
Respiratory symptoms, atopy and bronchial hyperreactivity in professional firefightersD Miedinger, P N Chhajed, D Stolz, et al.
HIV Medicine|September 8, 2009
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS)A U Scherrer, B Hasse, V von Wyl, et al.
The British Journal of Surgery|February 7, 2018
Systematic review and simulation study of ignoring clustered data in surgical trialsS Dell-Kuster, R A Droeser, J Schäfer, et al.
HIV Medicine|December 13, 2017
Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversionO T Stirrup, A J Copas, A N Phillips, et al.
HIV Medicine|November 8, 2017
Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infectionJ Young, C Smith, R Teira, et al.
HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.
AIDS (London, England)|November 4, 2000
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort StudyO T Rutschmann, P L Vernazza, H C Bucher, et al.
Pageof 9